title: The authors respond.
authors.affiliation: Department of Development and Regeneration, KU Leuven, Leuven, Belgium; Department of Orthopedics, University Hospital Leuven, Leuven, Belgium.
authors.forename: Anja
authors.initials: A
authors.lastname: Van Campenhout
authors.affiliation: Clinical Motion Analysis Laboratory, University Hospital Leuven, Leuven, Belgium; Department of Rehabilitation Sciences, KU Leuven, Leuven, Belgium.
authors.forename: Lynn
authors.initials: L
authors.lastname: Bar-On
mesh_terms: D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D002547:Cerebral Palsy / Q000534:rehabilitation*; D004185:Disability Evaluation; D005260:Female; D006801:Humans; D008297:Male; D009128:Muscle Spasticity / Q000188:drug therapy*; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D026741:Physical Therapy Modalities
chemical_list: D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A